Apollon Wealth Management, LLC
Position in ACTU — Actuate Therapeutics, Inc.
CIK 1764387
MOUNT PLEASANT, SC
Position in ACTU
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$21,439
New position
Shares Held
14,013
first reported quarter
Ownership
0.058%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 64 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Apollon Wealth Management, LLC holds $51,440,082 across 23 Biotechnology names. ACTU ranks #23 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
63,910 | $31,746,014 | |
| 2 | BMRN |
Biomarin Pharmaceutical Inc
|
137,661 | $7,876,962 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
6,662 | $4,154,023 | |
| 4 | RARE |
Ultragenyx Pharmaceutical Inc.
|
123,449 | $4,121,962 | |
| 5 | PTCT |
Ptc Therapeutics, Inc.
|
6,595 | $537,954 | |
| 6 | CRSP |
CRISPR Therapeutics AG
|
8,350 | $455,409 | |
| 7 | MRNA |
Moderna, Inc.
|
5,260 | $368,357 | |
| 8 | HURA |
TuHURA Biosciences, Inc./NV
|
156,519 | $366,254 |
All Filings in ACTU
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,439 | 14,013 | Shares | Sole | 2026-07-23 | |
| No filing history on record for this holder in this stock. | ||||||